This Article Full Text Full Text (PDF) All Versions of this Article: 51/3/676    most recent HYPERTENSIONAHA.107.101493v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muller, D. N. Articles by Hilgers, K. F. Search for Related Content PubMed PubMed Citation Articles by Muller, D. N. Articles by Hilgers, K. F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Related Collections ACE/Angiotension receptors Other hypertension Other Treatment

(Hypertension. 2008;51:676.)
© 2008 American Heart Association, Inc.

Original Articles

(Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats

Dominik N. Muller; Bernd Klanke; Sandra Feldt; Nada Cordasic; Andrea Hartner; Roland E. Schmieder; Friedrich C. Luft; Karl F. Hilgers

From the Medical Faculty of the Charité (D.N.M., S.F., F.C.L.), Experimental and Clinical Research Center, Franz Volhard Clinic, and HELIOS Klinikum Berlin-Buch, and Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany; and the Department of Nephrology and Hypertension (B.K., N.C., R.E.S., K.F.H.) and Childrens’ Hospital (A.H.), University of Erlangen-Nuremberg, Erlangen, Germany.

Correspondence to Karl F. Hilgers, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Loschgestrasse 8, 91054 Erlangen, Germany. E-mail karl.hilgers{at}rzmail.uni-erlangen.de

The (pro)renin receptor [(P)RR], a new component the renin-angiotensin system, was cloned recently. The (P)RR promotes direct mitogen-activated protein kinase signaling and nonproteolytic prorenin activation. We investigated the role of a (P)RR blocker, a peptide consisting of 10 amino acids from the prorenin prosegment called the "handle-region" peptide (HRP), on target organ damage in renovascular hypertensive 2-kidney, 1-clip (2K1C) rats. Vehicle-treated 2K1C rats were compared with HRP-treated 2K1C rats (3.5 µg/kg per day) and sham-operated controls. Vehicle-treated 2K1C rats developed hypertension (186±17 mm Hg), cardiac hypertrophy (3.16±0.16 mg/g), renal inflammation, fibrosis, vascular, and tubular damage. Chronic HRP treatment did not affect blood pressure (194±15 mm Hg), cardiac hypertrophy (2.97±0.11 mg/g), or renal damage. Furthermore, we investigated the renal renin and (P)RR expression. The clipped kidney of 2K1C and HRP-treated 2K1C rats showed a higher renin expression and juxtaglomerular index compared with sham-operated kidneys. The unclipped kidney showed suppressed renin expression. In contrast, (P)RR mRNA expression was not altered in any group. Plasma renin activity and aldosterone were increased in 2K1C rats compared with sham controls. HRP-treated 2K1C rats tended to lower plasma renin activity but showed similar aldosterone levels as vehicle-treated 2K1C rats. Our results indicate that blockade of the (P)RR with HRP does not improve target organ damage in renovascular hypertensive rats.

Key Words: renin • (pro)renin receptor • HRP • target organ damage • angiotensin • renovascular hypertension

This article has been cited by other articles:

				J. Peters, T. Schluter, T. Riegel, B. S. Peters, A. Beineke, U. Maschke, N. Hosten, J. J. Mullins, and R. Rettig Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1845 - H1852. [Abstract] [Full Text] [PDF]

				S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida (Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation Diabetes, July 1, 2009; 58(7): 1625 - 1633. [Abstract] [Full Text] [PDF]

				C. Mercure, G. Prescott, M.-J. Lacombe, D. W. Silversides, and T. L. Reudelhuber Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies Hypertension, June 1, 2009; 53(6): 1062 - 1069. [Abstract] [Full Text] [PDF]

				J. L. Wilkinson-Berka Prorenin and the (Pro)renin Receptor in Ocular Pathology Am. J. Pathol., December 1, 2008; 173(6): 1591 - 1594. [Abstract] [Full Text] [PDF]

				D. Susic, X. Zhou, E. D. Frohlich, H. Lippton, and M. Knight Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1117 - H1121. [Abstract] [Full Text] [PDF]

				M. J. Brown Aliskiren Circulation, August 12, 2008; 118(7): 773 - 784. [Abstract] [Full Text] [PDF]

				G. Nguyen and A. H. J. Danser Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents Exp Physiol, May 1, 2008; 93(5): 557 - 563. [Abstract] [Full Text] [PDF]

				D. J. Campbell Critical Review of Prorenin and (Pro)renin Receptor Research Hypertension, May 1, 2008; 51(5): 1259 - 1264. [Full Text] [PDF]

				F. C Luft The Bothrops legacy: Vasoactive peptides from Brazil Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1): 57 - 64. [PDF]